ABSTRACT NUMBER: ESOC2026A1132 HETEROGENEOUS TREATMENT EFFECTS OF TRADITIONAL CHINESE MEDICINE FYTF-919 (ZHONGFENG XINGNAO ORAL PRESCRIPTION) IN PATIENTS WITH ACUTE INTRACEREBRAL HAEMORRHAGE: SECONDARY ANALYSIS OF CHAIN TRIAL

作者
Weiyi Zhong,Dou Wang,Liling Zeng,Jianwen Guo,Craig S. Anderson,Lili Song
出处
期刊:European stroke journal [SAGE Publishing]
卷期号:11 (Supplement_1): i326-i327
标识
DOI:10.1093/esj/aakag023.568
摘要

Abstract Background and aims Although the CHAIN trial showed neutral overall effects of FYTF-919 on ICH, treatment responses appeared to vary across patient profiles. We aimed to characterise treatment-effect heterogeneity and identify potential subgroups that derive benefit from FYTF-919. Methods CHAIN was a prospective, randomised, double-blinded, placebo-controlled trial at 26 hospitals in China. Adults with acute moderate-to-severe ICH were randomly assigned to FYTF-919 or placebo for 28 days. The primary outcome was uw-mRS at 90 days. Baseline characteristics were assessed for effect modification using causal forest and non-linear regression, and further evaluated in categorised subgroups analyses with interaction terms added. This trial is registered at ClinicalTrials.gov, NCT05066620. Results Between Nov 24, 2021 and Dec 28, 2023, 1619 participants with available 90-day uw-mRS were included (801 FYTF-919; 818 placebo). Hematoma volume, age and time to randomisation were the strongest contributors to treatment-effect heterogeneity. Non-linear interaction was observed for hematoma volume (p=0·008). Patients with moderate hematoma (16-56mL) showed more favourable 90-day uw-mRS with FYTF-919 (difference 0·07, 95%CI 0·02 to 0·11), whereas no benefit was observed among small or large hematoma. Treatment effects also differed by time to randomisation (<15h vs. ≥15h, p=0·029 for interaction), with more favourable outcomes among participants randomised later. No heterogeneity was observed for other characteristics including age, GCS and hematoma location. Conclusions Treatment effects of FYTF-919 in acute ICH varied across hematoma volume and timing of randomisation. These findings suggest potential benefit in selected subgroups and warrant validation in future trials. Conflict of interest Weiyi Zhong, Dou Wang, Liling Zeng, Jianwen Guo, Craig Anderson, Lili Song: nothing to disclose Figure 1 - belongs to Results Figure 2 - belongs to Results

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
飞行雪绒发布了新的文献求助10
1秒前
深情安青的应助被初景采纳,获得10
1秒前
1秒前
冥土追魂发布了新的文献求助10
1秒前
周姮媛发布了新的文献求助10
2秒前
2秒前
h11的应助被欧皇采纳,获得10
2秒前
JamesPei的应助被ydygdy采纳,获得10
2秒前
sunnymoon发布了新的文献求助10
2秒前
汉堡包的应助被Willing采纳,获得10
2秒前
兴奋嵩完成签到 ,获得积分10
2秒前
2秒前
乐乐笑语的应助被不安鱼采纳,获得10
2秒前
薯饼完成签到,获得积分10
2秒前
林夕少爷完成签到,获得积分10
3秒前
3719left完成签到,获得积分10
3秒前
CHENG完成签到,获得积分20
3秒前
3秒前
小小的应助被七听采纳,获得100
3秒前
杨梅想早点毕业完成签到,获得积分10
3秒前
4秒前
keyan完成签到 ,获得积分10
4秒前
友人君完成签到,获得积分10
4秒前
王迪发布了新的文献求助10
4秒前
李爱国的应助被小马过河采纳,获得10
4秒前
5秒前
zh4n96y发布了新的文献求助10
5秒前
拉长的夜梦完成签到,获得积分10
5秒前
5秒前
5秒前
zcj发布了新的文献求助10
5秒前
清风与诗发布了新的文献求助20
6秒前
kk的应助被xi采纳,获得10
6秒前
大模型的应助被大方的凌翠采纳,获得10
6秒前
充电宝的应助被WY采纳,获得10
6秒前
Jacqueline完成签到,获得积分10
7秒前
yuan发布了新的文献求助10
7秒前
止咳片完成签到 ,获得积分10
7秒前
软包电芯完成签到,获得积分10
7秒前
贾克斯完成签到,获得积分20
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8161749
求助须知:如何正确求助?哪些是违规求助? 9556240
关于积分的说明 21733360
捐赠科研通 7751657
什么是DOI,文献DOI怎么找? 3427566
关于科研通互助平台的介绍 2552632
邀请新用户注册赠送积分活动 2472047